切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2025, Vol. 19 ›› Issue (02) : 180 -183. doi: 10.3877/cma.j.issn.1674-3946.2025.02.017.

论著

腹腔镜下胃癌D2根治+腹主动脉旁淋巴结清扫术治疗局部进展期胃癌的临床研究
邓崇文1,(), 廖喜望1, 施幼雄1, 龚俊1, 钟洪1   
  1. 1.417000 湖南娄底,湖南省娄底市中心医院
  • 收稿日期:2024-03-06 出版日期:2025-04-26
  • 通信作者: 邓崇文
  • 基金资助:
    娄底市应用技术研究与开发项目(娄科发〔2022〕32号)

Clinical study of laparoscopic D2 radical treatment of gastric cancer and paraaortic lymph node dissection in the treatment of locally advanced gastric cancer

Chongwen Deng1,(), Xiwang Liao1, Youxiong Shi1, Jun Gong1, Hong Zhong1   

  1. 1.Hunan Loudi Central Hospital, Loudi Hunan Province 417000,China
  • Received:2024-03-06 Published:2025-04-26
  • Corresponding author: Chongwen Deng
引用本文:

邓崇文, 廖喜望, 施幼雄, 龚俊, 钟洪. 腹腔镜下胃癌D2根治+腹主动脉旁淋巴结清扫术治疗局部进展期胃癌的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(02): 180-183.

Chongwen Deng, Xiwang Liao, Youxiong Shi, Jun Gong, Hong Zhong. Clinical study of laparoscopic D2 radical treatment of gastric cancer and paraaortic lymph node dissection in the treatment of locally advanced gastric cancer[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(02): 180-183.

目的

探讨腹腔镜胃癌D2根治合并腹主动脉旁淋巴结清扫(PAND)术治疗局部进展期胃癌的临床意义。

方法

回顾性分析2022年1月至2024年1月61例局部进展期胃癌患者资料,所有患者均行腹腔镜胃切除术,根据术中淋巴结清扫范围不同分为两组,对照组32例行D2淋巴结清扫术,观察组29例在此基础上行PAND。采用SPSS 26.0进行数据统计。围手术期指标等计量资料用(x±s)表示,行独立样本t检验;术后并发症等计数资料用[例(%)]描述,行χ2检验;利用Kaplan-Meier绘制生存曲线图,经Log-Rank检验分析两组生存情况。P<0.05为差异有统计学意义。

结果

观察组患者手术时间、淋巴结清扫数目显著多于对照组(P<0.05);两组术中出血量、引流管拔除时间、术后住院天数比较,差异未见统计学意义(P>0.05);观察组患者并发症总发生率(15.6%)与对照组(10.0%)对比,差异无统计学意义(P>0.05);观察组患者累积总生存率为86.2%,虽高于对照组的75.0%,但差异未见统计学意义(P=0.317)。

结论

局部进展期胃癌患者行D2+PAND治疗虽延长了手术时间,但可清扫出更多数目淋巴结,且不增加手术并发症风险,安全可行。

Objective

To investigate the clinical significance of laparoscopic D2 radical resection combined with paraaortic lymph node dissection (PAND) in the treatment of locally advanced gastric cancer.

Methods

Data of 61 patients with locally advanced gastric cancer from January 2022 to January 2024 were retrospectively analyzed.All patients underwent laparoscopic gastrectomy and were divided into two groups according to the scope of intraoperative lymph node dissection.32 patients in the control group underwent D2 lymph node dissection, and 29 patients in the observation group received ascending PAND on this basis.SPSS 26.0 was used for data statistics.Measurement data such as perioperative indexes were expressed with (x±s),and independent sample t test was performed.Postoperative complications and other statistical data were described by[cases (%)], and χ2 tests were performed.Survival curves were drawn by Kaplan-Meier, and survival conditions of the two groups were analyzed by Log-Rank test.P<0.05 was considered statistically significant.

Results

The operation time and the number of lymph node dissection in observation group were significantly higher than those in control group (P<0.05).There was no significant difference in the amount of blood loss, the time of drainage tube removal and the number of days in hospital between the two groups (P>0.05).There was no significant difference in the incidence of complications between the observation group (15.6%)and the control group (10.0%) (P>0.05).The cumulative overall survival rate of observation group was 86.2%,which was higher than that of control group (75.0%), but the difference was not statistically significant (P=0.317).

Conclusion

In patients with locally advanced gastric cancer, D2+PAND treatment can prolong the operation time, but more lymph nodes can be removed without increasing the risk of surgical complications, which is safe and feasible.

表1 两组局部进展期胃癌手术患者一般基线资料比较
表2 两组局部进展期胃癌手术患者围手术期指标比较(± s
表3 两组局部进展期胃癌患者不同淋巴结清扫范围患者术后并发症比较[例]
图1 两组局部进展期胃癌手术患者Kaplan-Meier 生存曲线
[1]
Yang WJ, Zhao HP, Yu Y, et al.Updates on global epidemiology,risk and prognostic factors of gastric cancer[J].World J Gastroenterol, 2023, 29(16):2452-2468.
[2]
牛福勇, 韩永军.3D腹腔镜近端胃癌根治术在直径>5cm的T3-4期胃癌患者中的应用研究[J/CD].中华普外科手术学杂志(电子版), 2021, 15(06): 657-660.
[3]
de Jongh C, Triemstra L, van der Veen A, et al.Pattern of lymph node metastases in gastric cancer: a side-study of the multicenter LOGICA-trial[ J].Gastric Cancer, 2022, 25(6): 1060-1072.
[4]
于鹏程, 徐志远, 王以, 等.胃癌行腹主动脉旁淋巴结清扫的研究进展[J].中国肿瘤临床, 2022, 49(17): 903-907.
[5]
Li JQ, He D, Liang YX.Current status of extended 'D2 plus'lymphadenectomy in advanced gastric cance[rJ].Oncol Lett ,2021, 21(6): 467.
[6]
Japanese Gastric Cancer Association.Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition[) J].Gastric Cancer, 2023,26(1): 1-25.
[7]
陈心足, 胡建昆, SIGES研究组.胃癌防控策略的探索与优化:流行病学、病原微生物及危险因素[J].中国普外基础与临床杂志, 2023, 30(01): 86-90.
[8]
黄昌明, 陈起跃, 刘治羽, 等.中国腹腔镜胃癌手术20年发展、问题与对策[J/CD].中华普外科手术学杂志(电子版), 2021,15(02): 123-128.
[9]
Lu S, Chen YG, Liu XW, et al.A phase II study of perioperative treatment in gastric cancer with No.16a2/b1 lymph node metastasis: DRAGON-06 tria[lJ].Future Oncol, 2022, 18(39):4239-4349.
[10]
严超, 陆晟, 燕敏, 等《.日本胃癌治疗指南2021(第6版)》解读及瑞金实践[J].外科理论与实践, 2023, 28(04): 326-354.
[11]
程向东, 张延强, 黄灵, 等.胃癌外科治疗的热点问题与展望[J].肿瘤学杂志, 2021, 27(02): 81-86.
[12]
宋武, 汪晓峰.腹腔镜胃癌根治术中No.16淋巴结清扫价值及技术要点[J].中国实用外科杂志, 2023, 43(09): 1012-1015.
[13]
Hikage M, Fujiya K, Kamiya S, et al.Prognostic factors in patients who received paraaortic lymph node dissection for locally advanced gastric cancer with extensive lymph node metastasis[ J].Langenbecks Arch Surg, 2022, 407(3): 1027-1037.
[14]
Ri M, Ohashi M, Eto K, et al.Favorable Outcomes of Neoadjuvant Chemotherapy and Limited Para-Aortic Lymph Node Dissection for Advanced Gastric Cancer with Para-aortic Lymph Node Metastasis[ J].World J Surg, 2021, 45(9): 2849-2859.
[15]
Sasako M, Sano T, Yamamoto S, et al.D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer[ J].N Engl J Med, 2008, 359(5): 453-462.
[16]
Ozmen M M, Zulfikaroglu B, Ozmen F, et al.D2 vs.D2 Plus Paraaortic lymph node dissection for advanced gastric cancer[ J].Turk J Surg, 2021, 37(1): 49-58.
[17]
崔耀夫, 董永红.进展期胃癌腹主动脉旁淋巴结清扫对患者生存预后的影响[J].中华肿瘤防治杂志, 2020, 27(S): 94, 96.
[1] 林填, 胡彦锋, 余江, 赵明利, 陈豪, 陈韬, 李国新. 单孔+1腹腔镜全胃切除、D2淋巴结清扫术[J/OL]. 中华普外科手术学杂志(电子版), 2021, 15(02): 143-143.
[2] 周福兴, 贺艳丽, 张潍. 单孔腹腔镜技术在子宫内膜癌全面分期手术中的应用[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(01): 55-57.
[3] 王细文, 刘恒炜, 黄桔园, 易跃雄, 张蔚. 单孔腹腔镜UGF两翼法腹主动脉旁淋巴结切除术[J/OL]. 中华腔镜外科杂志(电子版), 2023, 16(04): 246-248.
[4] 黄莉, 雷婷, 郭宏涛, 刘畅. 淋巴绘图下的腹主动脉旁淋巴结切除术[J/OL]. 中华腔镜外科杂志(电子版), 2021, 14(05): 315-317.
[5] 马丽芳, 邹冬玲, 周琦. 达芬奇机器人辅助腹主动脉旁淋巴结切除术在宫颈癌分期术中的应用[J/OL]. 中华腔镜外科杂志(电子版), 2020, 13(05): 278-282.
[6] 毛林, 张蔚, 胡晓霞. 宫颈癌腹腔镜腹主动脉旁淋巴结切除术的手术入路及解剖[J/OL]. 中华腔镜外科杂志(电子版), 2017, 10(02): 114-117.
[7] 何小艳, 张蔚, 刘静, 毛林. 腹腔镜下腹主动脉旁淋巴结清扫并发症[J/OL]. 中华腔镜外科杂志(电子版), 2016, 09(04): 253-256.
[8] 古朝阳, 邓祥兵, 王自强. 结直肠癌肝脏、腹主动脉旁淋巴结寡转移的MDT策略[J/OL]. 中华结直肠疾病电子杂志, 2017, 06(04): 330-335.
[9] 丁金路, 徐宗雪, 程敏. 顺阿曲库铵不同用药方案对腹腔镜胃切除术患者麻醉质量的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 373-377.
阅读次数
全文


摘要